Cardiac application of embryonic stem cells

( views:79, downloads:0 )
Author:
()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 55, Issue 05, 2003
DOI:
Key Word:
embryonic stem cell;myocardial infarction;cellular cardiomyoplasty;heart failure;myocarditis

Abstract: Cardiomyocytes deceased during myocardial infarction (MI) are replaced with non-contractile scar tissue, which has a great chance to cause heart failure. Repair of dead or injured myocardium and improvement of cardiac function remain a serious challenge for the therapy of heart failure. Recently, stem cells have been transplanted in experimental settings to replace lost myocardium. This article summarizes the recent experimental findings on transplantation of embryonic stem cells (ESCs) and their derived cells in animals with myocardial injury and highlights the progresses in research of these particular cell types. Beneficial effects of cell transplantation with other cell types in injured hearts have been detailed in other reviews.ESCs are pluripotent cells derived from early mammalian embryos at the blasto-stage. These cells have the capacity for prolonged undifferentiated proliferation or differentiation into all of specialized somatic cell types of the body in culture, including cardiomyocytes. Because of the great ability of proliferation and differentiation to mature tissues, ESCs are a potential valuable resource for cell therapy targeting regeneration of functional myocardium in diseased hearts. In recent animal studies intramyocardial transplantation of ESCs or their differentiated cardiac-like cells regenerated injured myocardium and improved heart function in infarcted animal models. In addition, intravenous infusion of ESCs significantly increased the survival rate and attenuated myocardial injury in viral myocarditic mice. Development and characterization of cardiomyocytes in vitro from human ESCs have been reported recently. However, many ethical, political, and scientific barriers have to be overcome before clinical utilization of human ESCs and their differentiated cells for treating end-stage cardiac diseases.

  • [1]Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N,Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344:1750 - 1757.
  • [2]Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac pro-genitors in transplanted human hearts. Circ Res 2002;90(6) :634 -640.
  • [3]Muller P, Pfeiffer P, Koglin J, Schafers H J, Seeland U,Janzen I, Urbschat S, Bohm M. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation 2002;106(1):31 -35.
  • [4]Deb A, Wang S, Skelding KA, Miller D, Simper D, Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 2003;107(9):1247-1249.
  • [5]Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994;264:98-101.
  • [6]Chiu RCJ, Zibaitis A, Kao RL. Cellular cardiomyoplasty:myocardial regeneration with satellite cell implantation.Ann Thorac Surg 1995;60:12-18.
  • [7]Li RK, Jia ZQ, Weisel RD, Mickle DAG, Zhang J, Mohabeer MK, Rao V, Ivanov RV Jr. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996;62:654-661.
  • [8]Leor J, Patterson M, Quinones MJ, Kedes LK, Kloner RA. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat: a potential method for repair of infarcted myocardium. Circulation 1996 ;94(Suppl GⅡ):Ⅱ332 - Ⅱ336.
  • [9]Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001 ;410:701 -706.
  • [10]Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuelear bone marrow cell transplantation in humans. Circulation 2002;106(15):1913-1918.
  • [11]Koh GY, Soonpaa MH, Klug MG, Field LJ. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol 1993 ;264(5 Pt 2) :H1727 -H1733.
  • [12]Tomita S, Li RK, Weisel RD, Mickle DAG, Kim EJ, Sakai T, Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100 (Suppl Ⅱ):Ⅱ247-Ⅱ256.
  • [13]Chedrawy EG, Wang JS, Nguyen DM, Shum-Tim D, Chiu RC. Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: anatomic basis for functional improvements. J Thorac Cardiovasc Surg 2002;124(3):584 -590.
  • [14]Scorsin M, Hagege AA, Marotte F, Mirochnik N, Copin H, Barnoux M, Sabri A, Samuel JL, Rappaport L, Menasche P. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation 1997;96(9Suppl):Ⅱ-188-193.
  • [15]Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasche P.Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2000; 119(6):1169-1175.
  • [16]Leor J, Prentice H, Sartorelli V, Quinones M J, Patterson M, Kedes LK, Kloner RA. Gene transfer and cell transplant: an experimental approach to repair a "broken heart". Cardiovasc Res 1997 ;35(3):431-441.
  • [17]Li RK, Weisel RD, Mickle DA, Jia ZQ, Kim EJ, Sakai T, Tomita S, Schwartz L, Iwanochko M, Husain M, Cusimano R J, Burns RJ, Yau TM. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg 2000;119(1):62-68.
  • [18]Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, Laird PW, Kedes L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002;34(2):107 116.
  • [19]Muller-Ehmsen J, Peterson KL, Kedes L, Whittaker P,Dow JS, Long TI, Laird PW, Kloner RA. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002; 105(14):1720-1726.
  • [20]Min JY, Sullivan MF, Yang Y, Zhang JP, Converso KL,Ke Q, Morgan JP, Xiao YF. Significant improvement of heart function by co-transplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs.Ann Thorac Surg 2002;74(5) :1568 - 1575.
  • [21]Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, Xiao YF. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Applied Physiol 2002 ;92:288 - 296.
  • [22]Naito H, Taniguchi S, Kawata T. Embryonic stem cell-derived cardiomyocyte transplantation into the infarcted myocardium. Heart Surg Forum 2002 ;6(1):1.
  • [23]Min JY, Yang Y, Sullivan MF, Ke Q, Converso KL,Chen Y, Morgan JP, Xiao YF. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003;125(2) :361-369.
  • [24]Yang Y, Min JY, Rana JS, Ke Q, Cai J, Chen Y, Morgan JP, Xiao YF. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 2002;93(3):1140 -1151.
  • [25]Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107: r75-r83.
  • [26]Strauer BE, Brehm M, Zeus T, Gattermann N, HernandezA, Sorg RV, Kogler G, Wernet P. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr 2001 ;24;126(34-35):932-938.
  • [27]Taylor DA. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure.Curr Control Trials Cardiovasc Med 2001; 2(5):208 210.
  • [28]Muller-Ehmsen J, Kedes LH, Schwinger RH, Kloner RA.Cellular cardiomyoplasty-a novel approach to treat heart disease. Congest Heart Fail 2002;8(4):220-227.
  • [29]Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 2002 ;91 (12):1092-1102.
  • [30]Anversa P, Leri A, Kajstura J, Nadal-Ginard B. Myocyte growth and cardiac repair. J Mol Cell Cardiol 2002;34(2):91-105.
  • [31]Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation 2003; 107(7):929-934.
  • [32]Evans M J, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292(5819):154-156.
  • [33]Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981;78(12) :7634 -7638.
  • [34]Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA,Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998;282(5391):1145-1147.
  • [35]Sissman NJ. Developmental landmarks in cardiac morphogenesis: comparative chronology. Am J Cardiol 1970;25(2) :141-148.
  • [36]Wobus AM, Wallukat G, Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 1991; 48:173-182.
  • [37]Maltsev VA, Rohwedel J, Hescheler J, Wobus AM. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types.Mech Dev 1993 ;44(1):41-50.
  • [38]Klug MG, Soonpaa MH, Field LJ. DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes. Am J Physiol 1995 ;269 :H1913- H1921.
  • [39]Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996;98: 216-224.
  • [40]Wesffall MV, Samuelson LC, Metzger JM. Troponin I isoform expression is developmentally regulated in differentiating embryonic stem cell-derived cardiac myocytes. Dev Dyn 1996;206:24-38.
  • [41]Westfall MV, Pasyk KA, Yule DI, Samuelson LC,Metzger JM. Ultrastructure and cell-cell coupling of cardiac myocytes differentiating in embryonic stem cell cultures.Cell Motil Cytoskeleton 1997;36:43-54.
  • [42]Kilborn MJ, Fedida D. A study of the developmental changes in outward currents of rat ventricular myocytes. J Physiol (Lond) 1990;430:37-60.
  • [43]Rohwedel J, Maltsev V, Bober E, Arnold HH, Hescheler J, Wobus AM. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 1994;164(1):87-101.
  • [44]Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J,Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108(3):407-414.
  • [45]Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002 ;91 (6) :501-508.
  • [46]Connold AL, Frischknecht R, Vrbova G. Survival of embryonic cardiac myocytes transplanted into host rat soleus muscle. J Muscle Res Cell Motil 1995;16(5):481-489.
  • [47]Min JY, Yang Y, Converso KL, Liu L, Morgan JP, Xiao YF. Improvement of heart function in postinfarcted rats by transplantation of embryonic stem cells. Circulation.2000 ;Young Investigated Award, 102 :Ⅱ35.
  • [48]Connold AL, Frischknecht R, Dimitrakos M, Vrbova G.The survival of embryonic cardiomyocytes transplanted into damaged host rat myocardium. J Muscle RESC Motil 1997 ;18(1):63-70.
  • [49]Etzion S, Battler A, Barbash IM, Cagnano E, Zarin P,Granot Y, Kedes LH, Kloner RA, Leor J. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001 ;33:1321 - 1330.
  • [50]Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, Stoecker E, Fleischmann M, Bohlen H, Stehle R, Kolossov E, Brem G, Addicks K, Pfitzer G, Welz A, Hescheler J, Fleischmann BK. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002;105(20):2435 -2441.
  • [51]Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000 ;343:1388-1398.
  • [52]Silver MA, Kowalczyk D. Coronary microvascular narrowing in acute murine Coxsackie B3 myocarditis. Am Heart J 1989;118:173-174.
  • [53]Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999;99:1091 -1100.
  • [54]Wang JF, Yang Y, Wang G, Min J, Sullivan MF, Ping P, Xiao YF, Morgan JP. Embryonic stem cells attenuate viral myocarditis in murine model Cell Transplant 2002;11(8) :753 -758.
  • [55]Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002;16(12):1558-1566.
  • [56]Perez-Terzic C, Behfar A, Mery A, van Deursen JM,Terzic A, Puceat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res 2003 ;92(4):444-452.
  • [57]Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, Opthof T, Brutel de la Riviere A, Tertoolen L, van der Heyden M, Pera M. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 2002;200(Pt 3):233-242.
  • [58]Vittet D, Prandini MH, Berthier R, Schweitzer A, MartinSisteron H, Uzan G, Dejana E. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996; 88(9):3424-3431.
  • [59]Hirashima M, Kataoka H, Nishikawa S, Matsuyoshi N,Nishikawa S. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 1999;93(4):1253-1263.
  • [60]Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S. Flkl-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408(6808):92-96.
  • [61]Yurugi-Kobayashi T, Itoh H, Yamashita J, Yamahara K,Hirai H, Kobayashi T, Ogawa M, Nishikawa S, Nishikawa SI, Nakao K. Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage.Blood 2003; 101(7):2675-2678.
  • [62]Van Meter CH, Claycomb WC Jr, Delcarpio JB, Smith DM, deGruiter H, Smart F, Ochsner JL. Myoblast transplantation in the porcine model: A potential technique for myocardial repair. J Thorac Cardiovasc Surg 1995; 110:1142 - 1148.
  • [63]Watanabe E, Smith DM Jr, Delcarpio JB, Sun J, Smart FW, Van Meter CH Jr, Claycomb WC. Cardiomyocyte transplantation in a porcine myocardial infarction model Cell Transplan 1998 ;7:239-246.
  • [64]Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC,Allidina Y, Liu P, Li RK. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002;123(6) :1132-1140.
  • [65]Kim EJ, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, Sakai T, Yau TM. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 2001; 122(5):963 - 971.
  • [66]Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001 ;414(6859) :98 - 104.
  • [67]Smith AG. Culture and differentiation of embryonic stem cells. J Tissue Culture Methods 1991 ;13:89 -94.
  • [68]Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji Guanju, Fleischmann B, Katus HA, Hescheler J,Franz WM. Retinoic acid accelerates embryonic stem cellderived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997 ;29(6):1525 - 1539.
  • [69]Boheler KR, Czyz J, Tweedie D, Yang HT, Anisimov SV,Wobus AM. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 2002;91 (3): 189 201.
  • [70]Hidaka K, Lee JK, Kim HS, Ihm CH, Iio A, Ogawa M,Nishikawa SI, Kodama I, Morisaki T. Chamber-specific differentiation of Nkx2. 5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J 2003; Feb 19[epub ahead of print].
  • [71]Yu Chen, Yinke Yang, Jamal S Rana, Qingen Kc, James P Morgan, Yong-Fu Xiao. Effects of vascular endothelial growth factor on proliferation and differentiation of embryonic stem cells. J Am Goll Cardiol 2003;41(6, Suppl A):273A.
  • [72]Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA,Benvenisty N. From the cover: effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000; 97(21):11307 - 11312.
  • [73]Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I,Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart,improving function and survival. Proc Natl Acad Sci USA 2001 ;98(18):10344 - 10349.
  • [74]Li D, ZhaoL, Liu M, DuX, DingW, ZhangJ, Mehta JL. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction.Am Heart J 1999;137:1145 -1152.
  • [75]Yu Chen, Qingen Kc, Yinke Yang, Jamal S Rana, Jian Tang, James P Morgan, Yong-Fu Xiao. Cardiomyocytes overexpressing TNF-α attract migration of embryonic stem cells via activation of p38 and c-Jun N-terminal kinase.FASEB J 2003;in press.
  • [76]Ildstad ST, Wren SM, Boggs SS, Hronakes ML, Vecchini F, Van den Brink MR. Cross-species bone marrow transplantation: evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment(rat-mouse). J Exp Med 1991 ;174(2) :467-478.
  • [77]Saito T, Kuang JQ, Bittira B, A1-Khaldi A, Chiu RC.Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002 ;74(1): 19 - 24.
  • [78]Xiao YF, Min JY, Morgan JP. Immunosuppression and xenotransplantation of cells for cardiac repair. Ann Thorac Surg 2003 ;in press.
  • [79]O'Shea KS. Embryonic stem cell models of development.Anatom Rec 1999 ;257:32 - 41.
  • [80]Fandrich F, Dresske B, Bader M, Schulze M. Embryonic stem cells share immune-privileged features relevant for tolerance induction. J Mol Med 2002;80(6):343 -350.
  • [81]Wobus AM. Potential of embryonic stem cells. Mol Aspects Med 2001 ;22(3) :149 - 164.
  • [82]Hughes S. Cardiac stem cells. J Pathol 2002;197(4) :468-478.
  • [83]Hassink RJ, Brutel de la Riviere A, Mummery CL, Doevendans PA. Transplantation of cells for cardiac repair. J Am Coll Cardiol 2003 ;41 (5) :711 - 717.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn